Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Bone Neoplasms × Exercise Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 12 Breast Neoplasms 11 Fatigue 6 Depression 4 Neoplasms 3 Multiple Myeloma 3 Head and Neck Neoplasms 3 Anxiety Disorders 3 Respiratory Aspiration 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lymphedema 2 Lung Neoplasms 2 Hypoventilation 2 Breast Cancer Lymphedema 2 Ventricular Dysfunction, Left 1 Uterine Cervical Neoplasms 1 Trismus 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Osteosclerosis 1 Osteoarthritis, Knee 1 Neurotoxicity Syndromes 1 Mesothelioma 1 Lymphoma, Follicular 1

Interventions

Gemcitabine 6 Doxorubicin 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Docetaxel 3 Cyclophosphamide 3 Cisplatin 3 Vincristine 2 Tranexamic Acid 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Nivolumab 2 Methotrexate 2 Methods 2 Interviews as Topic 2 Indocyanine Green 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tocilizumab 1 samarium Sm-153 lexidronam 1 regorafenib 1 poly ICLC 1 pegfilgrastim 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 fludarabine 1 flt3 ligand protein 1 endostar protein 1 eltrombopag 1 dinutuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04963517 2024-12-06

proGAIT

Universität Duisburg-Essen

Phase 2/3 Completed

Bone Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡